What we’re tracking on 10 December 2019
It’s another day in which the House dominates the nation’s news agenda, but there’s still no sign of the much-awaited…
Available in your choice of English or Arabic
It’s another day in which the House dominates the nation’s news agenda, but there’s still no sign of the much-awaited…
The House of Representatives had a busy first day back in session yesterday, with a pile of legislation receiving general…
The House of Representatives is back from recess today, and the big question isn’t what’s next on the legislative agenda,…
Retail appetite for Rameda’s IPO surgest on last day; offering closing 36.3x oversubscribed: Retail investors poured into Rameda Pharma’s 5%…
It’s the final day for retail investors look to subscribe to Rameda Pharma’s IPO: The penultimate day of Rameda’s retail…
IPO WATCH- Rameda retail offering 1.6x oversubscribed on second day of subscription: Rameda Pharma’s retail offering was 1.6x oversubscribed at…
IPO WATCH- Rameda Pharma retail offering oversubscribed on first day: The retail component of Rameda’s IPO was oversubscribed at the…
IPO WATCH- Market regulator gives Rameda green light on public subscription notice: The Financial Regulatory Authority (FRA) has approved Rameda…
Something went wrong. Please refresh the page and/or try again.
Queue